Sarki, M.; Ming, C.; Aissaoui, S.; Bürki, N.; Caiata-Zufferey, M.; Erlanger, T.E.; Graffeo-Galbiati, R.; Heinimann, K.; Heinzelmann-Schwarz, V.; Monnerat, C.;
et al. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. Cancers 2022, 14, 1636.
https://doi.org/10.3390/cancers14071636
AMA Style
Sarki M, Ming C, Aissaoui S, Bürki N, Caiata-Zufferey M, Erlanger TE, Graffeo-Galbiati R, Heinimann K, Heinzelmann-Schwarz V, Monnerat C,
et al. Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. Cancers. 2022; 14(7):1636.
https://doi.org/10.3390/cancers14071636
Chicago/Turabian Style
Sarki, Mahesh, Chang Ming, Souria Aissaoui, Nicole Bürki, Maria Caiata-Zufferey, Tobias Ephraim Erlanger, Rossella Graffeo-Galbiati, Karl Heinimann, Viola Heinzelmann-Schwarz, Christian Monnerat,
and et al. 2022. "Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort" Cancers 14, no. 7: 1636.
https://doi.org/10.3390/cancers14071636
APA Style
Sarki, M., Ming, C., Aissaoui, S., Bürki, N., Caiata-Zufferey, M., Erlanger, T. E., Graffeo-Galbiati, R., Heinimann, K., Heinzelmann-Schwarz, V., Monnerat, C., Probst-Hensch, N., Rabaglio, M., Zürrer-Härdi, U., Chappuis, P. O., Katapodi, M. C., & on behalf of the CASCADE Consortium.
(2022). Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. Cancers, 14(7), 1636.
https://doi.org/10.3390/cancers14071636